Chapter 1 | Argentina | |
1.01 | Introduction | |
1.02 | Patents | |
1.03 | Defenses Available to an Accused Infringer | |
Chapter 2 | Australia | |
2.01 | Patents | |
2.02 | Trade Mark/Trade Dress Protection for Pharmaceuticals | |
2.03 | Data Exclusivity and Public Access to Information | |
2.04 | The Drug Approval Process | |
2.05 | Packaging and Labeling | |
2.06 | Government Price Controls on Pharmaceuticals | |
2.07 | Government Drug Payment Plan | |
2.08 | List Of Cases | |
Chapter 3 | Brazil | |
3.01 | General Information on the Brazilian Industrial Property Law | |
Chapter 4 | Canada | |
4.01 | General Background | |
4.02 | Patents | |
4.03 | Trade-mark/Trade Dress Protection for Pharmaceuticals | |
4.04 | Data Exclusivity and Public Access to Information | |
4.05 | The Drug Approval Process | |
4.06 | Price Controls on Pharmaceuticals | |
4.07 | Public Drug Payment Plans | |
Chapter 5 | China | |
5.01 | Patents | |
5.02 | Trademark/Trade Dress Protection for Pharmaceuticals | |
5.03 | Data Exclusivity and Confidentiality of Information | |
5.04 | Drug Approval Process | |
5.05 | Packaging and Labeling | |
5.06 | Price Controls on Pharmaceuticals | |
5.07 | Public Drug Benefit Programs | |
Chapter 6 | The Czech Republic | |
6.01 | General Information | |
Chapter 7 | Europe | |
7.01 | Patents | |
7.02 | Trade Mark/Trade Dress Protection for Pharmaceuticals | |
7.03 | Data Exclusivity and Public Access to Information | |
7.04 | The Drug Approval Process | |
7.05 | Packaging and Labeling | |
7.06 | Government Price Controls on Pharmaceuticals | |
7.07 | Government Drug Payment Plans | |
Chapter 8 | France | |
8.01 | Patents | |
8.02 | Trademark/Trade Dress Protection for Pharmaceuticals | |
8.03 | Data Exclusivity and Public Access to Information | |
8.04 | The Drug Approval Process | |
8.05 | Packaging and Labeling | |
8.06 | Government Price Controls on Pharmaceuticals | |
8.07 | Government Drug Payment Plans | |
Chapter 9 | India | |
9.01 | General | |
9.02 | Patents | |
9.03 | Trade marks | |
9.04 | Control of Drug Manufacture and Sale | |
Chapter 10 | Israel | |
10.01 | Introduction | |
10.02 | Patents | |
10.03 | Trade-mark Protection for Pharmaceuticals | |
10.04 | Data Exclusivity and Public Access to Information | |
10.05 | The Drug Approval Process | |
10.06 | Bioequivalence And Generic Registration In Israel | |
Chapter 11 | Italy | |
11.01 | General Patent and Trademark Information | |
11.02 | Filing a Patent Application | |
11.03 | Patent Subject Matter for Pharmaceutical Inventions | |
11.04 | Validity Requirements for Pharmaceutical Inventions | |
11.05 | Patent Term and Term Extensions | |
11.06 | Patent Infringement | |
11.07 | Trademark/Trade Dress Protection for Pharmaceuticals | |
11.08 | Data Exclusivity and Public Access to Information | |
11.09 | Drug Approval Process | |
11.10 | Packaging and Labeling | |
11.11 | Government Price Controls on Pharmaceuticals | |
11.12 | Government Drug Payment Plans | |
Chapter 12 | Japan | |
12.01 | General | |
12.02 | Patents | |
12.03 | Trademark/Trade Dress Protection for Pharmaceuticals | |
12.04 | Data Exclusivity and Public Access to Information | |
12.05 | Drug Approval Process | |
12.06 | Government Price Controls on Pharmaceuticals | |
12.07 | Government Drug Payment Plans | |
Chapter 13 | Mexico | |
13.01 | Patents | |
13.02 | Trademark Protection for Pharmaceuticals | |
13.03 | Data Exclusivity and Public Access to Information | |
13.04 | The Drug Approval Process | |
13.05 | Packaging and Labeling | |
13.06 | Government Price Controls on Pharmaceuticals | |
13.07 | Government Drug Payment Plans | |
Chapter 14 | Poland | |
14.01 | General Information | |
14.02 | Trademark/Trade Dress Protection of Pharmaceuticals | |
14.03 | Approval of New Drugs | |
14.04 | Approval of Equivalent Drugs | |
14.05 | Access to Information and Data Exclusivity | |
14.06 | Packaging and Labeling of Medicinal Products | |
14.07 | Price Controls for Medicinal Products and Public Drug Payment Plans | |
Chapter 15 | South Africa | |
15.01 | General | |
15.02 | Patents | |
15.03 | Trade Marks/Trade Dress Protection for Pharmaceuticals | |
15.04 | Data Exclusivity and Public Access to Information | |
15.05 | The Drug Approval Process | |
15.06 | Packaging and Labeling of Pharmaceuticals | |
15.07 | Drug Payment Plans and Price Controls | |
Chapter 16 | Switzerland | |
16.01 | Patents | |
16.02 | Trademarks | |
16.03 | Data Exclusivity and Public Access to Information | |
16.04 | The Drug Approval Process | |
16.05 | Packaging and Labeling | |
16.06 | Price Controls on Pharmaceuticals | |
Chapter 17 | Taiwan | |
17.01 | Introduction | |
17.02 | Patents | |
17.03 | Trademark/Trade Dress Protection for Pharmaceuticals | |
17.04 | Data Exclusivity and Public Access to Information | |
17.05 | The Drug Approval Process | |
17.06 | Packaging and Labeling | |
17.07 | Government Price Controls on Pharmaceuticals | |
17.08 | Government Drug Payment Plans | |
Chapter 18 | United Kingdom | |
18.01 | Patents | |
18.02 | Trade Marks | |
18.03 | Data Exclusivity and Public Access to Information | |
18.04 | The Drug Approval Process | |
18.05 | Government Price Controls on Pharmaceuticals | |
18.06 | Government Drug Payment Plans | |
Chapter 19 | United States | |
19.01 | Patents | |
19.02 | Obtaining Regulatory Approval for a New Drug Product | |
19.03 | Obtaining Drug Approval for a Generic Version of a Previously Approved Product | |
19.04 | Trademark and Trade Dress | |
19.05 | Copyright and Labeling | |